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In the mammalian central nervous system (CNS), the inhibitory strength of chloride
(Cl−)-permeable GABAA and glycine receptors (GABAAR and GlyR) depends on the
intracellular Cl− concentration ([Cl−]i). Lowering [Cl−]i enhances inhibition, whereas raising
[Cl−]i facilitates neuronal activity. A neuron’s basal level of [Cl−]i, as well as its Cl− extrusion
capacity, is critically dependent on the activity of the electroneutral K+-Cl− cotransporter
KCC2, a member of the SLC12 cation-Cl− cotransporter (CCC) family. KCC2 deficiency
compromises neuronal migration, formation and the maturation of GABAergic and
glutamatergic synaptic connections, and results in network hyperexcitability and seizure
activity. Several neurological disorders including multiple epilepsy subtypes, neuropathic
pain, and schizophrenia, as well as various insults such as trauma and ischemia, are
associated with significant decreases in the Cl− extrusion capacity of KCC2 that result in
increases of [Cl−]i and the subsequent hyperexcitability of neuronal networks. Accordingly,
identifying the key upstream molecular mediators governing the functional regulation of
KCC2, and modifying these signaling pathways with small molecules, might constitute a
novel neurotherapeutic strategy for multiple diseases. Here, we discuss recent advances
in the understanding of the mechanisms regulating KCC2 activity, and of the role
these mechanisms play in neuronal Cl− homeostasis and GABAergic neurotransmission.
As KCC2 mediates electroneutral transport, the experimental recording of its activity
constitutes an important research challenge; we therefore also, provide an overview of
the different methodological approaches utilized to monitor function of KCC2 in both
physiological and pathological conditions.
Keywords: KCC2, intracellular chloride, GABA, neurons
INTRODUCTION
Since the discovery of the dichotomic action of GABAergic neu-
rotransmission more than two decades ago (Mueller et al., 1984;
Ben-Ari et al., 1989), important progress has been made in the
understanding of the role of intraneuronal Cl− concentration
([Cl−]i) in determining the action of GABA and glycine on post-
synaptic neurons. It is now clear that [Cl−]i is critical for proper
functioning of the CNS in physiological conditions, and alter-
ations of [Cl−]i are observed in multiple neurological disorders
that are characterized by GABAergic disinhibition (reviewed by
Ben-Ari et al., 2007; Kahle et al., 2008)
One of the key molecules responsible for determining [Cl−]i
in mature mammalian neurons, and also impaired in numerous
pathological conditions resulting in deranged [Cl−]i homeosta-
sis, is the K+-Cl− cotransporter KCC2, a neuron-specific Cl−
extruder of the cation-Cl− cotransporter gene family SLC12.
KCC2 plays a critical role in setting neuronal [Cl−]i; its deficiency
(Rivera et al., 1999) or absence (Hübner et al., 2001; Woo et al.,
2002; Balakrishnan et al., 2003; Zhu et al., 2005) raises [Cl−]i and
thereby decreases the inhibitory strength of GABA and glycine,
whose cognate receptors are ligand-gated ion channels permeable
to Cl− and HCO−3 ions. Impaired KCC2 activity and consequent
increases of [Cl−]i have been documented in epilepsy (Palma
et al., 2006; Huberfeld et al., 2007), neuropathic pain (Coull et al.,
2003), and spasticity following spinal cord injury (Cramer et al.,
2008; Shulga et al., 2008; Boulenguez et al., 2010). These and other
works (see Kahle et al., 2008; Blaesse et al., 2009; Ben-Ari et al.,
2012 for detailed reviews) have suggested that decreased KCC2
activity is a principal cause of the rise in [Cl−]i, that leads to
the depolarizing action and enhancement of neuronal network
activity in these paradigms.
Recent findings have provided novel insights into the dynamics
of KCC2 activity and [Cl−]i homeostasis in different pathology-
related experimental conditions, revealing the existence of com-
plex responses depending on the type of neuronal activity and
the timing of observation (e.g., Khirug et al., 2010; Pellegrino
et al., 2011; Shulga et al., 2012). In parallel, other studies strongly
contributed to the understanding of the signaling pathways
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controlling KCC2 activity (e.g., Puskarjov et al., 2012; Bos et al.,
2013; Gagnon et al., 2013; Ivakine et al., 2013; Markkanen et al.,
2013; De Los Heros et al., 2014). In the present work we review
recent compelling findings, highlight unresolved questions, and
discuss the technical challenges that underlie the study of KCC2.
OVERVIEW OF KCC2 BASIC PROPERTIES
Several recent reviews have provided detailed analysis of the
KCC2, its expression profile, physiological roles and implications
in different neurological disorders (e.g., Gamba, 2005; Medina
and Chudotvorova, 2006; Kahle et al., 2008, 2013; Blaesse et al.,
2009; Chamma et al., 2012; Gagnon and Delpire, 2013). Here, to
avoid repeating these reviews, we highlight briefly only some of
KCC2 properties required as background for further discussion
on the molecular determinants of the activity-dependent control
of the transporter.
KCC2 is one of nine cation-chloride cotransporters (CCCs)
encoded by SLC12 family genes. It shares high homology with
three other K+-Cl− cotransporters (KCC1, KCC3, and KCC4),
however it is distinct from these and other CCCs transporters by
its unique importance for functioning of CNS: (i) KCC2 is the
only CCC transporter expressed preferentially in neurons; (ii) it
is characterized by a progressive increase in expression during
development; (iii) KCC2 shows activity in isotonic conditions;
(iv) KCC2 plays a critical role in establishing neuronal [Cl−]i and
(v) it is involved in the control of numerous neuronal processes
including migration, dendritic outgrowth, formation of synaptic
connections, and spine morphology.
KCC2 was cloned in 1996 by homology with the KCC1
cotransporter from a rat brain cDNA library (Payne et al., 1996).
This, and numerous other studies have characterized KCC2
as a transporter expressed exclusively in neurons of the CNS
(reviewed by Blaesse et al., 2009), however some recent works
showed also KCC2 expression in human fetal lens epithelial cell
line (Lauf et al., 2008, 2012), chicken cardiomyocytes (Antrobus
et al., 2012) and cancer cells (Wei et al., 2011) suggesting that
functioning of KCC2 extends beyond the CNS. The silencing of
KCC2 in mice (Hübner et al., 2001; Woo et al., 2002; Zhu et al.,
2008; Khalilov et al., 2011) as well as KCC2-like genes in worms
(CE-KCC-2, Tanis et al., 2009; Bellemer et al., 2011) and flies (dm-
kcc, Hekmat-Scafe et al., 2006, 2010) produces severe changes of
the neuronal network properties leading to appearance of seizure
activity, increased neuron hyperexcitability and modifyied for-
mation of synaptic connections. The silencing of other members
of SLC12 gene family expressed in brain (NKCC1, KCC1, KCC3,
and KCC4) lead to much less pronounced changes of the pheno-
type (see Gagnon and Delpire, 2013 for most recent review on
genetically engineered CCC knockouts).
The secondary and tertiary structure of KCC2 and the other
KCCs is unknown. Based on hydropathy analysis of KCC2 pro-
tein, Payne et al. (1996) proposed a putative model of KCC2,
including 12 transmembrane domains and intracellular N- and
C-termini. The authors predicted four glycosylation sites on the
3rd putative extracellular loop and highlighted a potential tyro-
sine phosphorylation site at position 1087. So far, this is the only
model proposed. It is widely explored in drawings illustrating
putative structure of the KCC2 in many reviews and original data
FIGURE 1 | Regulatory sites on KCC2 protein. Depicted is a schematic
representation of the amino acid residues and domains in KCC2 that have
been implicated in the control of intrinsic KCC2 transport activity or in its
cell surface stability and/or membrane internalization.
publications (e.g., Li et al., 2007; Zhao et al., 2008). The KCC2
scheme drawn in the present review (Figure 1) has been also
inspired by the original drawing by Payne et al. (1996). The func-
tional importance of different structural elements of the KCC2
is also little studied. The region forming ion-transporting ele-
ment of the KCC2 andmechanism controlling intrinsic activity of
the transporter remain unclear (see below for more details). An
important aspect of KCC2 that may affect activity of this trans-
porter is its ability to oligomerize, and this issue may be one of
the most challenging in the elucidation of KCC2 function and
regulation.
KCC2 is a secondary-active electroneutral transporter that car-
ries K+ and Cl− ions in a 1:1 stoichiometry. The direction of the
ion transport depends on the sum of chemical gradients of K+
and Cl− (Payne, 1997). When close to the chemical equilibrium,
even slight changes in the concentration of either ion lead to a
change of the direction of the ion transport (Payne, 1997). This
property of the KCC2 is largely used during measurements of the
KCC2 activity by mean of 86Rb+, Tl+ or NH+4 influx (see inset
Box for details).
DIVERSITY OF ACTIVITY- AND PATHOLOGY-DEPENDENT
CHANGES OF KCC2 FUNCTION
KCC2 CHANGES RELATED TO PHYSIOLOGICAL PATTERNS OF
NEURONAL ACTIVITY
Whether physiological patterns of neuronal activity control devel-
opmental enhancement of KCC2 function remains controversial.
At least three studies have provided data supporting the idea
that chronic blockade of GABAergic (Ganguly et al., 2001; Leitch
et al., 2005) or glycinergic (Shibata et al., 2004) inputs in devel-
oping neuronal networks inhibits the developmental increase in
Frontiers in Cellular Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 27 | 2
Medina et al. Functional regulation of KCC2
KCC2 functional expression. In contrast, other studies have not
found significant changes in KCC2 functional expression after
prolonged inhibition of GABAergic neurotransmission (Ludwig
et al., 2003; Titz et al., 2003). The later conclusion does not
exclude, however, that the activity might contribute to fine adjust-
ments of the post-translational regulation (such as phosphory-
lation) and activation of plasmalemmal KCC2 function. Indeed,
a critical role of the brain-derived neurotrophic factor (BDNF)
and other trophic factors in the control of the developmental
expression of KCC2 has been shown (Kelsch et al., 2001; Ludwig
et al., 2011a,b). Given that neuronal activity regulates release of
BDNF from both pre- and post-synaptic terminals (Kuczewski
et al., 2008, 2010; Matsuda et al., 2009), it is plausible that BDNF
and/or other trophic factors contribute to activity-dependent
modulation of KCC2 in a context-dependent manner.
An important process in the maturation of glutamatergic
networks is the specific form of plasticity resulting from co-
incident pre- and post-synaptic spiking (Debanne and Poo,
2010). Similarly, spike-time-dependent plasticity has been shown
to exist for GABAergic synapses (Woodin et al., 2003). Most
intriguingly, within a sub-time domain, this new form of plas-
ticity is dependent on changes of [Cl−]i. A suggested critical step
in the mechanism is a rapid postsynaptic change in the efficiency
of chloride extrusion by KCC2 (Fiumelli et al., 2005).
PATHOLOGY-RELATED CHANGES OF THE KCC2 EXPRESSION
Currently there is a large number of observations describing
a strong decrease in KCC2 expression in different pathologies,
including temporal lobe epilepsies (Palma et al., 2006; Huberfeld
et al., 2007; Bragin et al., 2009; Barmashenko et al., 2011), focal
cortical dysplasia (Munakata et al., 2007; Shimizu-Okabe et al.,
2011; Talos et al., 2012), ischemia (Galeffi et al., 2004; Papp
et al., 2008; Jaenisch et al., 2010), as well as pathologies asso-
ciated with different types of axonal injury (Coull et al., 2003;
Shulga et al., 2008; Boulenguez et al., 2010). Although the primary
mechanisms initiating down-regulation of KCC2 during these
pathologies are not known, the common point between them is a
strong decrease of mRNA and protein expression levels. The exact
mechanisms triggering inactivation of the KCC2 function are not
yet well understood. Several groups have shown that epileptic-
like neuronal activity itself could serve as triggering event. For
instance, Nardou et al. (2009) showed suppression of the KCC2
function after induction of the epileptiform-like activity in the
entire immature (P5-P7) rat hippocampal preparation. Rivera
et al. (2004) found out that induction of epileptic-like activity to
acute hippocampal slices rapidly (30–60min) reduced expression
of KCC2 in the CA1 region of the hippocampus and suggested
a critical role of the glutamate and TrkB receptors in the pro-
cesses. These results, however, were updated recently by Puskarjov
et al. (2012) who showed that the half–life of plasma membrane
KCC2 under control conditionsmight be significantly longer than
previously reported. The difference between the two publications
may be mainly attributed to differences in slice preparation. In
the work by Puskarjov and collaborators, great care was taken to
minimize damage of slices during preparation. In addition, they
found that the mechanism for activity-dependent degradation of
plasma membrane KCC2 requires Ca2+-dependent activation of
the protease calpain. To achieve similar levels of KCC2 down-
regulation as Rivera et al. (2004), the authors had to incubate
slices with a higher concentration of NMDA (100μM) and for
a longer time (4 h). At these doses, NMDA triggers several neu-
rotoxic signaling cascades (Hardingham et al., 2002; Ivanov et al.,
2006), reviewed by Medina (2007) and Hardingham and Bading
(2010). A rapid NMDA receptor-dependent KCC2 inactivation
was also reported in two other studies performed on cultured
hippocampal neurons (Lee et al., 2011; Pellegrino et al., 2011).
Many studies reporting a global pathology-dependent down-
regulation of KCC2 expression mentioned also no-change or
up-regulation of KCC2 in a sub-population of neurons surviving
excitotoxic or ischemic insults. For example, Conti et al. (2011)
demonstrated an up-regulation of KCC2 cotransporter in human
peritumoral epileptic cortex (Conti et al., 2011). Huberfeld et al.
(2007) have shown robust KCC2 staining in some subicular pyra-
midal cells in human temporal lobe epilepsy (TLE) brain sections.
Jaenisch et al. (2010) have found a high level of KCC2 expres-
sion in infarct core neurons surviving a focal ischemic insult.
Papp et al. (2008) found a delayed pattern of down-regulation
in interneurons in the same model. Consistent with these data,
Pellegrino et al. (2011) showed that all neurons surviving excito-
toxic treatment with NMDA restored their normal Cl− extrusion
ability and increased their expression of KCC2.
While robust pathology-like activation of a neuronal net-
work may lead primarily to inactivation of KCC2, short activity
episodes might induce functional up-regulation. For instance,
Khirug et al. (2010) found that a single seizure episode in vivo,
as well as brief seizure-like activity in vitro in neonates, induced
a potent increase in KCC2 plasma membrane expression (with
unchanged total KCC2 expression) that correlated with enhance-
ment in the efficacy of GABAergic inhibition. The up-regulated
KCC2 activity was reported also in several other studies (Khirug
et al., 2005; Banke and Gegelashvili, 2008; Chorin et al., 2011; Bos
et al., 2013); however, it remains unclear how the described mod-
ulations of KCC2 activity are related to physiological or pathology
conditions.
Since many of the discussed above reports show that restora-
tion of the physiological level of Cl− results in normal neuronal
functioning, this suggests that targeting of the KCC2 and/or
NKCC1 could be an efficient therapeutic strategy (reviewed by
Kahle et al., 2008; Löscher et al., 2013). Regarding this, recent
studies concentrated on high-throughput screening of the com-
pounds capable to selectively inhibit the NKCC1 (Delpire et al.,
2009, 2012) and activate KCC2 (Gagnon et al., 2013). Further
optimization of the reported compounds as well as creation of
new agents targeting specific signaling pathways upstream of
KCC2 and/or NKCC1 will make in nearest future an important
breakthrough for KCC2-related therapy.
CELL-INHERENT LEVELS OF KCC2 CONTROL
TRANSCRIPTIONAL REGULATION OF KCC2 EXPRESSION
Most mature CNS neurons exhibit high levels of KCC2 expres-
sion, while low expression is detected in immature neurons
(reviewed in Blaesse et al., 2009; Chamma et al., 2012). KCC2
mRNA levels are increased with neuronal maturation, KCC2 pro-
tein expression shows concordance with the mRNA level (Lu
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et al., 1999; Li et al., 2002; Stein et al., 2004). RNA interference
approaches, such as anti-sense oligonucleotides (Rivera et al.,
1999) or specific siRNAs (Bortone and Polleux, 2009; Pellegrino
et al., 2011; Gauvain et al., 2011; Succol et al., 2012), lead to a
reduction of KCC2 protein and a resulting loss of KCC2 activity.
Thus, the control at the mRNA level is an efficient way to regulate
the long-term activity of KCC2.
Selective decrease in KCC2 mRNA has been observed during
neurological disorders (Palma et al., 2006; Huberfeld et al., 2007),
after sustained interictal-like activity (Rivera et al., 2004), and
after axonal injury (Nabekura et al., 2002; Toyoda et al., 2003;
Shulga et al., 2008, 2009). Activity-dependent decreases in KCC2
mRNA might therefore be an important factor contributing to
the down-regulation of KCC2 activity in certain pathological con-
ditions. At least 10 putative transcription factor binding sites
have been identified in the SLC12A5 gene encoding KCC2 pro-
moter and proximal intron-1 regions (Uvarov et al., 2006; Uvarov,
2010). These sites are highly conserved elements among promoter
regions of other mammalian KCC2 genes. Transcription factor
early growth response 4 (Egr4) has been identified as a potent
regulator of KCC2 expression (Uvarov et al., 2006), which medi-
ates BDNF-dependent KCC2 transcription in immature neurons
(Ludwig et al., 2011b). Another regulatory element in the KCC2
promoter is the E-box, that binds the ubiquitously expressed
upstream stimulating factors USF1 and 2, thus contributing
KCC2 up-regulation in the developing cortex (Markkanen et al.,
2008). In addition, two neuron-restrictive silencing elements
(NRSE) were found in SLC12A5; however, the data on whether
they are involved in the developmental up-regulation of KCC2
are controversial (Karadsheh and Delpire, 2001; Uvarov et al.,
2005; Yeo et al., 2009). The role of other putative transcription
factor binding elements in the KCC2 promoter remains obscure.
One important task will be to characterize in more detail the
regulatory elements controlling SLC12A5 transcription.
KCC2 ASSEMBLY
Numerous studies suggest that, by analogy with other types of
transporters and Cl− channels, the CCC family members func-
tion as oligomers (McKee et al., 2000; Moore-Hoon and Turner,
2000; Casula et al., 2001; De Jong et al., 2003; Starremans et al.,
2003; Simard et al., 2004; Blaesse et al., 2006; Parvin et al.,
2007; Simard et al., 2007; Pedersen et al., 2008; Casula et al.,
2009; Warmuth et al., 2009). With regard to KCC2, the abil-
ity of this molecule to form molecular complexes corresponding
to mono-, di-, tri-, and tetrameric complexes was first demon-
strated by Blaesse et al. (2006). The authors showed also a clear
age-dependence of the oligomerization: the immature brains
were characterized by higher content of the monomers, whereas
adult tissue produced mostly oligomeric forms of the KCC2.
An additional set of data demonstrating the ability of KCC2
to form dimers in vivo comes from studies of the distribu-
tion (Markkanen et al., 2013) and interaction (Uvarov et al.,
2009) between KCC2a and KCC2b isoforms (Uvarov et al.,
2007). Using the native perfluorooctanoate (PFO)-PAGE system,
as well as a co-immunoprecipitation assay, Uvarov et al. (2009)
have shown that KCC2a and KCC2b isoforms form homo- and
heterodimers in vivo and in heterologous HEK-293 expression
system. Despite multiple evidence describing oligomerization of
KCC2, the functional context of this protein complex remains
unclear. Is it critical for translocation to plasmamembrane? What
is the number of subunits that form the ion-transport unit?
Is oligomerization involved in KCC2 surface expression and/or
internalization? These and other questions remain to be answered
and should be a subject for future studies.
By reviewing results of the KCC2 oligomerization studies,
we have to be aware of some technical problems that one may
encounter during analysis of the KCC2 using Western blot.
Due to yet unidentified reasons, KCC2 is prone to forming
SDS-resistant high molecular aggregates during standard pro-
tein extraction and solubilization procedures that are normally
used for denaturation and dissociation of protein complexes
(Gallagher, 2012). By performing Western blot analysis of the
KCC2, we have found that in addition to the age-dependent
changes in KCC2 oligomeric/monomeric ratio described in the
above study (Blaesse et al., 2006), the ability to form oligomers
strongly depends on the experimental procedure and is differ-
ent for endogenously expressed KCC2 and for KCC2 overex-
pressed in heterologous systems (Figure 2). A very rapid protein
extraction reduces the formation of the KCC2 oligomeric com-
plexes under SDS-denaturating conditions, whereas long extrac-
tion (more than 4min) increases the probability to get dimers.
Interestingly, once the KCC2 dimer complexes are formed, we
could not dissociate them to monomeric structure using boil-
ing with SDS or in combination with high concentration (8
M) of urea at high temperature, a treatment that works effi-
ciently to disrupt such strong molecular complexes as NMDA
receptors-associated postsynaptic densities (Krapivinsky et al.,
2003, 2004).
SURFACE EXPRESSION, TURNOVER
Plasma membrane insertion, surface stabilization, and inter-
nalization of the molecule constitute one more important
FIGURE 2 | Complexity of interpretation of KCC2 oligomerization.
Formation of KCC2 dimer-like complexes depends on the protein extraction
procedure and is different for endogenous and over-expressed KCC2. KCC2
extraction using a rapid procedure (<1min) either from human cortices or
rat brains generates a single band of ∼140 kDa. The extracts prepared from
similar brain samples using the same solutions but with a longer overall
time of extraction (> 4min) always give at least two bands corresponding
to monomer (140 kDa) and dimer (280–300 kDa) of KCC2. The extraction of
eGFP-KCC2 over-expressed in HEK-293 cells resulted in the appearance of
two bands independently on the procedure of extraction. Similar two-band
expression profile of KCC2 was obtained after over-expression of different
KCC2 forms (with or without additional tags) into different cell lines (PC-12
and Neuro2a).
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mechanism of KCC2 regulation. Numerous studies have found
that pathological-like patterns of neuronal activity initiate rapid
withdrawal of the KCC2 from plasma membrane that leads
to a reduction of KCC2-mediated ion-transport (Rivera et al.,
2004; Lee et al., 2007, 2010, 2011; Wake et al., 2007; Puskarjov
et al., 2012; Chamma et al., 2013). Using an elegant approach
of visualizing KCC2 internalization harboring an extracellu-
lar tag, Zhao and colleagues have shown a critical role of
the cytoplasmic C- and not N-termini for KCC2 trafficking
(Zhao et al., 2008). The authors also localized in the KCC2 C-
terminus a novel non-canonical di-leucine motif (657LLXXEE662)
that seems to be essential for the constitutive internalization of
the transporter and for binding to the clathrin-binding adap-
tor protein-2 complex. Several phosphorylation sites on the C-
terminus have been implicated in mechanisms controlling KCC2
turnover (see below “phosphorylation” chapter for details and
Figure 1).
The internalization of overexpressed KCC2 is controlled by
the clathrin-mediated endocytosis pathway in HEK-cells (Zhao
et al., 2008) and can be prevented by an inhibitor of the clathrin
pathway in cultured neuronal cells (Lee et al., 2011). However,
no systematic work was performed to characterize the recycling
mechanism involved or the signaling pathways controlling the
KCC2membrane insertion. A recent study (Puskarjov et al., 2012)
launched the discussion on the timing of the KCC2 turnover
in neuronal membrane. Previous work (Rivera et al., 2004),
which was performed using a biotinylation approach and hip-
pocampal slices prepared using a slice chopper (i.e., resulting
in a significant number of damaged cells), suggested that half
of the KCC2 molecules are renewed in neuronal plasma mem-
brane within 30–40min. Using a different experimental approach
and slices prepared using a vibratome (i.e., with a lower rate
of neuron damage), Puskarjov et al. (2012) estimated the half
time of KCC2 turnover to be much longer (several hours or
even days). On the other hand, a study performed using cul-
tured hippocampal neurons showed that 45-min treatment of
neurons with dynasore, an inhibitor of the endocytosis, produced
twofold increase of the surface expression of the KCC2 (Lee et al.,
2010), indicating the existence of a relatively rapid constitutive
KCC2 endocytosis in this model. A further evidence supporting
the high rate of the KCC2 turnover was obtained in a heterol-
ogous expression system (HEK-293 cells) where over-expressed
KCC2 showed a half-time turnover rate close to 10min (Lee
et al., 2007; Zhao et al., 2008). Thus, the timing and mecha-
nisms controlling KCC2 surface expression remain to be fully
elucidated.
REGULATION OF THE INTRINSIC KCC2 ACTIVITY
The structural elements of KCC2’s ion-transport unit are not
known. Unlike other members of the KCC family (KCC1, KCC3,
and KCC4), which become active only after osmotic stress
(reviewed by Flatman, 2008; Blaesse et al., 2009), KCC2 is able
to extrude Cl− in isotonic conditions. The over-expression of
this transporter in heterologous expression systems (Payne, 1997;
Williams and Payne, 2004) or neuronal cells (Chudotvorova et al.,
2005; Lee et al., 2005; Pellegrino et al., 2011; Acton et al., 2012)
produces a clearly detectable ion flux that could be rapidly (within
few seconds) and reversibly inhibited using high concentrations
of furosemide, a sulfamoylbenzoic acid “loop” diuretics (Payne,
1997; Williams and Payne, 2004; Friedel et al., 2013). These data
suggest that, when expressed in the plasma membrane, KCC2
operates as constitutively active K+-Cl− transporter.
Several groups have identified in the KCC2 molecule different
regions and amino acid residues that regulate the ion-transport
activity. Hartmann et al. (2010) found that mutation of four
evolutionarily conserved cysteine residues in the large extracellu-
lar loop of KCC2 (C287, C302, C322, C331, Figure 1) inhibited
86Rb+ flux mediated by the transporter without affecting its
surface expression. Interestingly, mutation of the correspond-
ing cysteines in KCC4, which is the closest to KCC2 member
of the SLC12 family, did not affect the ion transport. These
data suggest a distinct organization of ion-transport mechanism
in KCC2 and KCC4, thus further enhancing exclusiveness of
the KCC2. An important role in KCC2-mediated ion transport
plays also C568, located inside the 10th putative transmem-
brane domain (Reynolds et al., 2008). Mutation of this residue
(C568A) makes KCC2 inactive, but it remains unclear whether
C568A mutation inhibits intrinsic activity or affects membrane
targeting of the molecule. A study performed by Horn et al.
(2010), described a decreased interaction of the KCC2C568A
mutant with cytoskeleton-associated 4.1N protein, and suggested
that the C568A mutation causes changes in the tertiary struc-
ture of the molecule. Additional analysis is necessary to clar-
ify the mechanism of how the C568A mutation silences KCC2
activity.
As illustrated in Figure 1, the N- and C- terminal domains of
KCC2 and other members of KCC subfamily, are both located
intracellularly. Several sets of data suggest that both domains can
regulate intrinsic activity of the transporter. Thus, by expression
in Xenopus oocytes of different KCC1 constructs with truncated
intracellular regions, Casula et al. (2001) found that deletion of
either N- or C- termini abolished ion transport activity of KCC1
without affecting transporter expression at the oocyte surface.
Consistent with this finding, Li et al. (2007) showed that trun-
cation of the N-terminus of KCC2 inhibited its ion-transport
activity and did not affect the surface expression of the protein
(Figure 1). A further evidence highlighting the importance of
the KCC C-terminus in controlling the intrinsic property of ion
transport was found in a study by Rinehart et al. (2009). Authors
showed that phosphorylation of KCC3 at two newly identified
sites (T991 and T1048) strongly inhibited the ion-transport activ-
ity of the transporter without modifying its surface expression.
Age-dependent changes of the phosphorylation status of equiv-
alent threonine sites in the KCC2 molecule (T906 and T1007)
were reported in the same study; however it remains unclear
whether phosphorylation of the KCC2 at these residues modifies
its intrinsic activity or surface expression.
The leucine 675 (L675) identified by Döding et al. (2012) is
onemore residue critically involved in KCC2 activity: its mutation
to alanine (L675A) strongly reduced 86Rb+ flux mediated by the
KCC2 without affecting the surface expression of the transporter
in mammalian cell lines.
It had been known for a long time that KCC2 could be con-
stitutively active in isotonic conditions in HEK293 cells (Payne,
Frontiers in Cellular Neuroscience www.frontiersin.org February 2014 | Volume 8 | Article 27 | 5
Medina et al. Functional regulation of KCC2
1997), CHO cells (Strange et al., 2000) and in Xenopus oocytes
(Strange et al., 2000; Song et al., 2002; Gagnon et al., 2006a). In
contrast to KCC2, several studies revealed no significant cotrans-
porter activity of KCC4 under isotonic conditions, but found that
KCC4 could be strongly (about 20-fold) activated by hypotonic
swelling (Mercado et al., 2000; Song et al., 2002). To iden-
tify molecular mechanisms underlining this difference, Mercado
and coauthors used Xenopus oocytes and multiple KCC2-KCC4
chimeric constructs, and found a C-terminal region unique to
KCC2 (ISO-domain, amino acids 1021–1035) that is both nec-
essary and sufficient for the isotonic KCC2 activity (Mercado
et al., 2006). A recent study confirmed important role of ISO
domain by illustrating in transfected cultured hippocampal neu-
rons that KCC2mutant with deleted ISO domain showed reduced
ion transport activity, whereas insertion of the ISO domain into
KCC4 transporter, which is inactive under isotonic conditions,
rendered it fully operational (Acton et al., 2012). Of notice, by
using different KCC2-KCC4 chimera constructs overexpressed in
Xenopus oocytes, Bergeron et al. (2006) obtained almost identical
to Mercado et al. (2006) results showing that the deletion of dis-
tal KCC2 region strongly reduced KCC2 activity under isotonic
conditions, whereas insertion of this domain to KCC4 potently
activated transporter. However, after analysis of many other KCC2
and KCC4 mutants authors were not convinced that the ISO seg-
ment is “a prerequisite for K+-Cl− cotransport to occur under
isotonic conditions.” Clearly, a characterization of the mechanism
of ISO domain action is one more challenge in the KCC2 field.
Taken together, the above data suggest that both N- and C-
terminal domains of KCC might be directly involved in the
control of the ion-transport unit; however, the mechanisms of
their regulatory actions are not known. An important task for
future studies will be to answer these questions by analysis of the
three-dimensional structure of KCC proteins.
SIGNALING PATHWAYS THAT CONTROL KCC2 ACTIVITY
Many signaling molecules have been implicated in the control of
KCC2 function (Figure 3). Some of these molecules and pathways
have been explored in detail, whereas many others remain to be
characterized. Below, we overview these pathways based on their
major regulatory functions.
BDNF AND OTHER TROPHIC FACTORS
At least three trophic (growth) factors have been identified as effi-
cient modulators of KCC2 functional expression: BDNF, Insulin-
Like Growth Factor 1 (IGF-1), and Neurturin (Kelsch et al., 2001;
Ludwig et al., 2011a; Shulga et al., 2012). Among them, the
regulatory effects of BDNF on KCC2 are the most thoroughly
characterized.
First evidence for the regulatory action of BDNF in devel-
oping neurons was presented by Aguado et al. (2003), who
showed that in vivo transgenic over-expression of BDNF strongly
increases KCC2 mRNA. Later the deletion of the receptor TrkB
was shown to strongly decrease KCC2 mRNA (Carmona et al.,
2006). Whether these effects are observed at the protein expres-
sion levels have so far not been reported in the literature.
Consistent with this study, the application of BDNF to imma-
ture hippocampal cultures significantly increases the expression
of KCC2 protein through Egr4-dependent KCC2 transcription
(Ludwig et al., 2011b). Interestingly, in more mature cultures
BDNF produced a decrease in KCC2 expression, thus reveal-
ing that the action of BDNF depends on the maturational state
of neurons (see for review (Ferrini and De Koninck, 2013). So
far, there is no evidence describing the regulatory action of the
BDNF on the post-translational level at early stages of neuronal
development.
In contrast to immature neurons, the exposure of adult neu-
rons to BDNF in vivo and in vitro decreases KCC2 expression and
function. BDNF decreases KCC2mRNA levels (Rivera et al., 2002;
Shulga et al., 2008), total KCC2 protein expression (Rivera et al.,
2004), as well as tyrosine-phosphorylated (Wake et al., 2007) and
membrane-inserted (Boulenguez et al., 2010) fractions of KCC2.
Consistent with these findings, over-expression of BDNF in vivo
produced a depolarizing shift of the GABA reversal potential in
dorsal spinal cord lamina I (L1) neurons, presumably reflecting a
decrease in KCC2 function (Coull et al., 2003, 2005).
Therefore, in mature neurons, application of exogenous BDNF
induces a down-regulation of the KCC2 function. Endogenously
released BDNF may therefore be a good candidate to mediate the
activity-dependent down-regulation of KCC2. In support of this
hypothesis, Rivera et al. (2004) showed that scavenging of endoge-
nous BDNF, or inhibition of signaling downstream from BDNF
TrkB receptors, effectively prevented activity-dependent reduc-
tion of KCC2 mRNA and protein. Several other studies have also
reported a critical role of BDNF in the change of the inhibitory
strength of GABA following axonal injury (Coull et al., 2005;
Shulga et al., 2008; Boulenguez et al., 2010; Zhang et al., 2013).
Intriguingly, BDNF application on neurons after injury, which
are characterized by a decreased level of KCC2 expression, pro-
duced effects opposite to those observed in naive tissue, namely
up-regulation of KCC2 surface expression (Shulga et al., 2008;
Boulenguez et al., 2010). One plausible explanation is that injured
neurons acquire properties of immature ones in order to launch a
repair program (Kahle et al., 2008; Shulga et al., 2008, 2012).
Both during development (Westerholz et al., 2013) and in axo-
tomized tissue (Shulga et al., 2009; Shulga and Rivera, 2013), the
regulatory action of BDNF is tightly related to the thyroid hor-
mone metabolism. The fact that thyroxine can bi-directionally
regulate the expression of KCC2 in the same manner as BDNF
would indicate that this effect could be mediated through BDNF
signaling (Friauf et al., 2008; Shulga et al., 2009). Interestingly, the
effect of thyroxin on KCC2 appears to be insensitive to BDNF sig-
naling blockage indicating yet another pathway for regulation of
KCC2 expression.
PHOSPHORYLATION
It has been long time appreciated that K+-Cl− cotransport in
non-excitable cells can be potently regulated by phosphoryla-
tion (Russell, 2000; Blaesse et al., 2009). Extrapolating these data
to neuronal K+-Cl− transport, several studies have made an
attempt to characterize the role of protein phosphorylation in
the functioning of the KCC2 (Kahle et al., 2013). Large number
of putative KCC2 phosphorylation sites were shown to con-
tribute into the control of transporter activity and/or its surface
expression (Figure 1). Numerous studies have highlighted also
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FIGURE 3 | Signaling pathways controlling KCC2 function. The
regulation of KCC2 activity is mediated by many proteins including
kinases and phosphatases. It affects either the steady state protein
expression at the plasma membrane or the KCC2 protein recycling. All
the different pathways are explained and discussed in the main text.
The schematic drawings of KCC2 as well as other membrane
molecules do not reflect their oligomeric structure. GRFα2, GDNF family
receptor α2; BDNF, Brain-derived neurotrophic factor; TrKB, Tropomyosin
receptor kinase B; Insulin, Insulin-like growth factor 1 (IGF-1); IGFR,
Insulin-like growth factor 1 receptor; mGluR1, Group I metabotropic
glutamate receptor; 5-HT-2A, 5-hydroxytryptamine (5-HT) type 2A
receptor; mAChR, Muscarinic acetylcholine receptor; NMDAR,
N-methyl-D-aspartate receptor; mZnR, Metabotropic zinc-sensing receptor
(mZnR); GPR39, G-protein-coupled receptor (GPR39); ERK-1,2,
Extracellular signal-regulated kinases 1, 2; PKC, Protein kinase C;
Src-TK, cytosolic Scr tyrosine kinase; WNKs1–4, with-no-lysine [K] kinase
1–4; SPAK, Ste20p-related proline/alanine-rich kinase; OSR1, oxidative
stress-responsive kinase -1; Tph, Tyrosine phosphatase; PP1, protein
phosphatase 1; Egr4, Early growth response transcription factor 4; USF
1/2, Upstream stimulating factor 1, 2.
different phosphorylation-related signaling pathways contribut-
ing to the control of KCC2 activity (Figure 3). Below we review
the recent evidence and make an attempt to classify them with
regard to the phosphorylation type (serine/threonine and tyro-
sine) and kinases implicated into the post-translational regulation
of the KCC2. We emphasize, in particular, the discrepancies
between different works and highlight unsolved questions.
Serine-threonine phosphorylation
To date, serine 940 (S940), localized in the cytoplasmic C-
terminal domain of KCC2, is the only known residue whose
phosphorylation enhances KCC2 activity. This residue has been
identified using in vitro screening of the KCC2-derived pep-
tides directly phosphorylated by protein kinase C (PKC) (Lee
et al., 2007). Dephosphorylation of S940 leads to inactivation of
KCC2-mediated ion transport and increases endocytosis of the
transporter. A high level of S940 phosphorylation is seen under
resting conditions in heterologous expression systems and cul-
tured hippocampal neurons, as revealed using an antibody raised
against the phosphorylated form of KCC2 S940 (Lee et al., 2011).
Thus, the PKC-dependent phosphorylation of S940 in the C-
terminus of KCC2 is critical for maintenance of the KCC2 activ-
ity under physiological conditions. The mechanisms controlling
S940 are not identified yet. At least three studies have described
the PKC dependent regulation of KCC2 during physiologically-
relevant processes including: (i) activity-dependent attenuation
of the KCC2 function in immature cultured neuronal cells
(Fiumelli et al., 2005), (ii) tonic activation of the KCC2 by
group Imetabotropic glutamate receptors (mGluR1s) (Banke and
Gegelashvili, 2008), and (iii) activation of the KCC2 via sero-
tonin type 2A receptors (Bos et al., 2013). However, it remains
unclear whether PKC-dependent regulation of KCC2 activity in
the above-mentioned studies, was direct or via some interme-
diate signaling molecules. Treatment of cultured hippocampal
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neurons with glutamate provoked a rapid dephosphorylation of
S940 residue that was NMDA receptor and protein phosphatase-
1 dependent (Lee et al., 2011). An important task would be to
determine whether the described signaling pathway contributes
to decrease of the KCC2 activity following neurological patholo-
gies. Lee et al. (2007) also identified another serine residue
(S728) whose mutation to alanine (S728A, dephosphorylated-
like form) produced a constitutive increase of the KCC2 activity.
Unfortunately, the authors did not study how S728 phosphory-
lation modifies the surface expression of the transporter and did
not identify the pathway controlling this phosphorylation site.
Rinehart et al. (2009) identified two threonine residues con-
served in other KCC members (T906 and T1007 on the isoform
b of rat KCC2 (accession number NP_599190)) whose phos-
phorylation strongly inhibited the transporter activity, whereas
dephosphorylation rendered transporters constitutively active.
T906 is partially phosphorylated in neonatal mouse brain and
dephosphorylated in adult brain, suggesting a potential contri-
bution of T906/T1007 dephosphorylation to functional KCC2
up-regulation during development. However, a systematic anal-
ysis of KCC2 phosphorylation at these sites in discrete anatomic
regions during brain development is required. Engineering KCC2
T906A (or E)/T1007A (or E) double knock-in mice would be
valuable in this regard.
The WNK (with-no-lysine [K]) family of serine-threonine
kinases comprises four members (WNK1, WNK2, WNK3,
and WNK4) that together with SPAK, a Ste20p-related
proline/alanine-rich kinase (Johnston et al., 2000) and OSR1, an
oxidative stress-responsive kinase -1 (Tamari et al., 1999) form
a powerful signaling cascade involved in control of swelling-
induced regulation of CCC family protein members (see for
review Delpire and Gagnon, 2008; Kahle et al., 2010). All these
kinases are expressed also in the CNS, but their functional
role in neurons is not known. Importantly, the activity of the
WNK-SPAK pathway is regulated by extracellular osmolality and
intracellular Cl− concentration (Zagórska et al., 2007; Thastrup
et al., 2012). The 4 members of WNK family have been shown
to effectively inhibit the activity of the KCC2 cotransporter
exogenously overexpressed in neurons (Inoue et al., 2012) or in
Xenopus oocytes (Kahle et al., 2005; De Los Heros et al., 2006;
Gagnon et al., 2006b; Rinehart et al., 2011). Taken together, the
above evidence indicates the importance of detailed evaluation of
the WNK-SPAK/OSR1 phosphorylation cascade in control of the
KCC2 function.
Toward this goal, the role of KCC2 T906 and T1007 phos-
phorylation during brain development was recently studied by
Inoue et al. (2012) using an elegant in utero electroporation
approach and over-expression of KCC2 mutants mimicking
hyper- and de-phosphorylated forms of transporter (T906E +
T1007E and T906A + T1007A, respectively) in rat cortex. Inoue
et al. (2012) suggested that the phosphorylation of these residues
in immature brains is maintained by taurine acting through
the WNK-SPAK/OSR1 phosphorylation cascade. The proposed
scheme was based, however, exclusively on evidence obtained
using application of exogenous taurine and exogenous over-
expression of wild type and mutant KCC2 and WNK1 kinase
constructs.
An important future task would be to verify the proposed
hypothesis using models involving silencing of the endogenous
molecules (WNK and SPAK), and to biochemically demonstrate
how inhibition of WNK-SPAK alters KCC2 phosphorylation.
Very recently de Los Heros et al. revealed that theWNK-regulated
SPAK/OSR1 kinases directly phosphorylate KCC2 at T1007 (site
2), but not at T906 (site 1), and inhibition of WNK-SPAK signal-
ing with a chemical inhibitor activates K-Cl cotransporter activity
in cells by decreasing T1007 > T906 inhibitory phosphorylation
in ES cells (De Los Heros et al., 2014). SPAK/OSR1 is also neces-
sary for KCC2 T1007 but not T906 phosphorylation in ES cells.
This is of high interest, given efforts aimed at finding chemical
activators of KCC2 to restore ionotropic inhibition. Perhaps a
novel way of activating KCC2 in certain cellular contexts would
be to oppose the action of inhibitory kinases, such as WNK/SPAK
(Kahle et al., 2013). While there are no classic knockout mouse
models available for WNK1 or OSR1 due to their requirement for
embryogenesis (Xie et al., 2013), exploring the roles of SPAK (and
other WNKs, like WNK3) in KCC2 regulation in vivo should be
possible using knockout mice (Yang et al., 2010; Mederle et al.,
2013) along with other transgenic mice which express SPAK har-
boring a point mutation that renders them unable to be activated
by WNK kinases (Rafiqi et al., 2010).
Tyrosine phosphorylation
KCC2 phosphorylation at tyrosine residues (TP, tyrosine phos-
phorylation) was shown in several studies (Stein et al., 2004;
Wake et al., 2007; Watanabe et al., 2009; Lee et al., 2010), how-
ever its importance for KCC2 functioning remains obscure.While
some studies showed the existence of the KCC2 TP under phys-
iological conditions in rodent’s cortex (Stein et al., 2004) and
primary hippocampal cultures (Wake et al., 2007; Watanabe et al.,
2009), others did not observe the basal TP under control con-
ditions in cultured hippocampal neurons, although strong TP
was observed after cultures treated with phosphatase inhibitors
(Lee et al., 2010). Wake et al. (2007) clearly showed that neu-
ronal network activity, oxidative stress, and treatment with BDNF
all lead to a strong decrease of KCC2 TP. In contrast, Lee et al.
(2010) observed a robust increase of KCC2 TP in brain slices
obtained from rats after pilocarpine-induced status epilepticus,
as well as in primary neuronal cultures treated with carbachol -
an agonist of acetylcholine receptors. Finally, by comparing the
influence of different experimental conditions on the KCC2 TP
level, EGABA, and distribution of the KCC2 protein levels, Wake
et al. (2007) and Watanabe et al. (2009) concluded that “direct
tyrosine phosphorylation of KCC2 results in membrane clusters and
functional transport activity” (Watanabe et al., 2009). However,
based on the comparison of KCC2 TP levels, surface expression
of the biotinylated KCC2 fraction, and total KCC2 expression,
Lee et al. (2010) provided an opposite conclusion stating that
KCC2 tyrosine phosphorylation promotes KCC2 internalization
and lysosomal degradation.
Many explanations for these discrepancies are possible; how-
ever the most reasonable one seems to be that the treatments
utilized to activate/inhibit TP in the mentioned studies were
different. All employed treatments (H2O2, BDNF, 0 Mg2+, car-
bachol, pilocarpine, blockers of kinases and phosphatases) are
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able to modify the activity of different signaling pathways, includ-
ing differential modulation of tyrosine kinases and phosphatases,
as well as serine/threonine kinases, which itself can produce
dual modulation of the KCC2 when acting through S940 or
T906/T1007 (see above). Clearly, additional studies are required
to clarify the question.
So far, two amino acid residues (Y903 and Y1087) were iden-
tified on KCC2 as potential carriers of tyrosine phosphorylation
signal (Lee et al., 2010). Authors found that mutations of these
residues to phenylalanine (Y903/1087F), which mimic dephos-
phorylated state, almost fully abolished the tyrosine phosphory-
lation state of the KCC2 protein exogenously overexpressed in
HEK-293 cells. Using biotinylation assays, the authors showed
that the Y903/1087F KCC2 mutant strongly increases the surface
expression of KCC2, providing an additional argument for the
TP-dependent internalization and degradation of KCC2. While
the Y903 residue was characterized only recently, the Y1087
amino acid has been a subject of several studies that have resulted
in contradictory conclusions. The Y1087 residue was first high-
lighted on a widely used KCC2 scheme presented by Payne et al.
(1996) as the tyrosine residue conserved through evolution in
all members of KCC and NKCC family transporters. Strange
et al. (2000) showed that mutation of this residue to aspartate
(Y1087D, mimicking a hyperphosphorylated state) fully abol-
ished activity of the KCC2 transporter, whereas Y1087F mutation
did not modify the KCC2-mediated ion transport. The authors,
however, did not observe the change in the surface expression of
the mutants in the Xenopus oocyte expression system, and they
also could not find any experimental evidence to support the
importance of tyrosine phosphorylation in the control of KCC2
activity. A full inactivity of KCC2 construct carrying Y1087D
mutation and overexpressed in brain-derived GT1-7 cell line was
also reported by Watanabe et al. (2009). Consistent with observa-
tion by Strange et al. (2000), authors did not find any changes
in the surface expression of the Y1087D mutant compared to
the wild type KCC2 (biotinylation assay). Interestingly, in their
study, Watanabe et al. (2009) considered the Y1087D mutant
of KCC2 as non-phosphorylated mutant. This was surprising as
aspartate has totally different structure as compared to the tyro-
sine. Usually, to mimic the non-phosphorylated state of tyrosine
researches use phenylalanine, an amino acid identical to tyro-
sine, with the exception of the absence of the phosphorylatable
hydroxyl group (see Anthis et al., 2009 for detailed discussion on
the strategy of tyrosine residues replacement). Given that Strange
et al. (2000) found a strong difference in the activity of Y1087F
and Y1087D mutants, the Y1087D mutation should be rather
considered as phosphorylation-like mutation. Unfortunately, in
their work Watanabe et al. (2009) did not compare the action
of Y1087D with alternative Y1087F mutant. The inactivity of
Y1087D mutant was confirmed several other times in other het-
erologous systems and cultured neurons (Chudotvorova et al.,
2005; Akerman and Cline, 2006; Pellegrino et al., 2011). The
above mentioned studies, however, used the Y1087D mutation as
an experimental tool and did not analyse the mechanisms leading
to the inactivation of KCC2 activity.
Thus, there is a good agreement between all existing
studies that Y1087D mutation, that potentially mimics the
phosphorylated-like state of the residue, inactivates KCC2 over-
expressed in oocytes (Strange et al., 2000), mammalian cell lines
(Watanabe et al., 2009) and neurons (Chudotvorova et al., 2005;
Akerman and Cline, 2006; Pellegrino et al., 2011). In opposite,
the mutation Y1087F, mimicking de-phosphorylated-like state of
KCC2 residue, does not affect KCC2 transport in oocytes (Strange
et al., 2000) and potentiates it in HEK-293 cells (Lee et al., 2010).
Taken together, these data strongly suggest that Y1087 phospho-
rylation reduces KCC2 activity, whereas its de-phosphorylation
potentiates the transporter. Due to discrepancies in the results
characterizing the surface expression of Y1087D mutants, the
mechanism controlling KCC2 activity (change in the surface
expression vs. change of the intrinsic activity) remains unclear.
What is the relationship between Y903/Y1087 phosphory-
lation and endogenous KCC2 tyrosine phosphorylation? The
Y903/Y1087 residues were detected in HEK-293 expression sys-
tem as unique phosphorylation residues whose mutation fully
abolished exogenous KCC2 phosphorylation. These data do not
exclude an existence of additional residues accessible for phos-
phorylation by tyrosine kinases in native neuronal environment.
The phosphorylation of these other residues might produce
opposite effects than mutations in Y903/1087. Therefore, one
cannot exclude differential effects of TP on endogenous KCC2
and on KCC2 mutated at one or two tyrosine amino acids.
Clearly, more scrupulous quantitative analysis is required to
answer the following questions: (i) what is the basal level of KCC2
tyrosine phosphorylation in different in vitro preparations (acute
slices, organotypic slices, primary neuronal cultures) compared to
maximal phosphorylation level achieved in presence of the acti-
vators of the TP and inhibitors of the phosphatases, (ii) what
is the basal level of the KCC2 TP in vivo (compared to in vitro
models), (iii) how many tyrosine residues could be phosphory-
lated in native neuronal environment, (iv) what are the functional
consequences (ion-transport activity, surface expression, protein
degradation) of the phosphorylation/dephosphorylation of the
KCC2 at distinct tyrosine residues?
Finally, numerous studies provided evidence of the KCC2 con-
trol via at least two distinct TP-dependent pathways involving
cytosolic c-Scr kinase (Kelsch et al., 2001) and BDNF-dependent
TrkB receptor tyrosine kinase (Rivera et al., 2002, 2004; Coull
et al., 2005; Boulenguez et al., 2010). Each of these kinases might
regulate large number of signaling cascades. An important task
would be to uncover the exact regulatory pathways controlling
KCC2 activity.
ZN2+-DEPENDENT CONTROL
Interesting data from groups of Hershfinkel and Aizenman
(Hershfinkel et al., 2009; Chorin et al., 2011; Saadi et al.,
2012) describe bi-directional Zn2+-dependent control of KCC2
(Figure 3). On one hand, intracellular Zn2+ in micromolar con-
centrations rapidly inhibits KCC2 activity (Hershfinkel et al.,
2009). Although the mechanism of Zn2+ action is not clear,
the finding indicates existence of a mechanism allowing inhi-
bition of the intrinsic activity of KCC2. On the other hand,
extracellular Zn2+ released from mossy fiber terminals, strongly
activates KCC2 by increasing its surface expression (Chorin et al.,
2011). Putatively, metabotropic zinc-sensing receptor (mZnR) is
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encoded by orphan Gq-coupled receptor (GPR39) and is coupled
to phospholipase C (PLC)/extracellular-signal-regulated kinases
(ERKs) pathway; the silencing of GPR39 or inhibition of PLC or
ERKs abolished the Zn2+ -dependent activation of KCC2 (Chorin
et al., 2011). Consistent with a high rate of KCC2 turnover (Rivera
et al., 2004), the authors have suggested that the increased surface
expression of KCC2 is due to the inhibition of transporter inter-
nalization and/or degradation (Chorin et al., 2011). However,
given recent evidence (see below chapter “Surface expression,
turnover” and Puskarjov et al., 2012), one cannot exclude that
Zn2+ potentiates the plasmalemmal insertion of the KCC2. The
Zn2+-dependent control of KCC2 activity is one more subject in
the KCC2 field requiring detailed analysis.
PROTEIN-PROTEIN INTERACTION
One more regulatory mechanism of KCC2 activity is through its
direct interaction with other proteins (Figure 4). The first such
interaction was described by Inoue et al. (2004) showing that
brain-type creatine kinase (CKB) interacts with KCC2 and acti-
vates the transporter in HEK-293 cells (Inoue et al., 2004, 2006).
Ikeda et al. (2004) found an intriguing interaction between the
α2 subunit of the Na-K-ATPase pump and KCC2 that may stand
for the breathing malfunction found in mice lacking the Na-K-
ATPaseα2 subunit (Atp1a2−/−). These mice display decreased
functional activity of KCC2 and have abnormal spontaneous res-
piratory rhythm activity, similarly to the KCC2−/− mice. KCC2
FIGURE 4 | Proteins directly interacting with KCC2. The scheme shows
membrane and cytoplasmic proteins that have been found to directly
interact with KCC2. It is currently unclear whether these proteins form one
big KCC2 containing complex or whether they all are combined in multiple
distinct KCC2 containing pools (e.g., plasmalemmal vs. sub-membrane
vesicular pools). Na+-K+-ATPase α2, subunit α2 of the Na+-K+-ATPase
pump; CIP1, the cation-chloride cotransporter interacting protein 1; Neto2,
neuropilin and tolloid like-2; βPix, beta isoform of the Rac/Cdc42 guanine
nucleotide exchange factor; Rac, small GTPase of the Rho family; Pak,
p21-activated serine/threonine-protein kinase kinase; Cof1, cofilin-1; CKB:
brain-type creatine kinase; PAM, protein associated with Myc; 4.1N,
cytoskeleton-associated protein.
interacts also with other unrelated proteins such as the protein
associated withMyc (PAM) via its RCC1 (Regulator of Chromatin
Condensation) domain, resulting in the functional regulation of
KCC2 activity in HEK-293 cells (Garbarini and Delpire, 2008),
or with the cation-chloride cotransporter interacting protein 1
(CIP1) (Wenz et al., 2009), but the functional significance of this
latter link in neurons remains unknown.
Furthermore, the cytoskeleton-associated protein 4.1N inter-
acts with the cytoplasmic carboxy-terminus of KCC2 and is
involved in dendritic spine formation (Li et al., 2007) and the
plasticity of AMPA receptors (Gauvain et al., 2011). Interrupting
the KCC2:4.1N interactions enhanced lateral diffusion of KCC2
away from excitatory synapses (Chamma et al., 2013). These
results indicate a role for 4.1N in the local stabilization of KCC2
at the plasma membrane. Although lateral KCC2 diffusion was
enhanced by NMDA receptor activity, the pathophysiological
relevance of this is unknown.
Another molecule interacting with KCC2 is the single-pass
transmembrane protein neuropilin and tolloid like-2 (Neto2)
(Ivakine et al., 2013). Neto2 is required to maintain the normal
abundance of KCC2 and specifically associates with the active
oligomeric form of the transporter. Loss of the Neto2:KCC2
interaction reduced KCC2-mediated Cl− extrusion, resulting in
decreased synaptic inhibition in hippocampal neurons. Presently,
the activity-dependent pathways controlling KCC2 via interaction
with Neto2 are unknown, but consistent with Neto2 being part of
a neuronal scaffolding platform (Tang et al., 2012), other stud-
ies will likely characterize the role of the KCC2:Neto2 interaction
in neuronal plasticity or during excitotoxic events that affect the
scaffold protein organization.
A recent finding describes a direct interaction between KCC2
and the beta isoform of the Rac/Cdc42 guanine nucleotide
exchange factor (betaPIX). The synergetic action of KCC2 and
betaPIX leads to decreased cofilin phosphorylation and change
of glutamatergic synapse properties (Ludwig et al., 2013) but
the importance of this interaction for activity-dependent signal
transfer needs to be determined.
LIPID RAFTS
At least two studies have suggested an important role of the
lipid rafts in the control of KCC2 activity (Hartmann et al.,
2009; Watanabe et al., 2009). Lipid rafts are specialized mem-
brane microdomains, enriched in glycosphingolipids and gly-
coproteins, serving as organising centers for the assembly of
signalingmolecules and control of their activity (for recent review
see Lingwood and Simons, 2010). Both, Hartmann et al. (2009)
and Watanabe et al. (2009) illustrated that in neurons approxi-
mately 50% of KCC2 is associated with lipid raft markers, whereas
remaining transporter molecules are linked to non-rafts mark-
ers. However, author’s conclusions on the importance of the
function of the rafts-like organization for KCC2 were opposite:
Hartmann et al. (2009) claimed that, when in rafts, KCC2 is in
an inactive form, whereas Watanabe et al. (2009) were convinced
that functional KCC2 forms rafts-like clusters. These contradic-
tory assumptions, however, were made based on results obtained
using different experimental paradigms, by employing different
and wide-range acting pharmacological agents, and by exploring
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Box 1 | How to Measure KCC2 Ion-Transport Activity.
Due to its electroneutrality, the KCC2 transport does not generate ion current. Therefore the electrophysiological approaches used to
directly monitor opening of ion channels are not applicable to the analysis of KCC2, as well as of other members of CCC family. To bypass
this problem, researchers measure consequences of transporter activity, i.e., the dynamic changes of the intracellular concentration of
either K+ or Cl−.
Flame photometry . The first studies characterizing activity of the endogenous cation-Cl−-dependent ion transporters determined changes
in the intracellular content of Na+, K+, and Cl− by flame photometry (Geck et al., 1980) or by analysing 24Na+ and 40K+ radioactivity
(Kregenow, 1971). Amazingly, these and other pioneer works studying ion fluxes through endogenous transporters determined the exact
stoichiometry of Na+-K+-Cl− (1:1:2) and K+-Cl− (1:1) co-transport, characterized the ion specificity, and described the requirement of Cl−
for operation of Na+-K+-Cl− and K+-Cl− transporters (Haas, 1994). These properties were confirmed many times and are considered
presently as landmarks for the NKCC and KCC subfamilies of transporters (Blaesse et al., 2009).
86RB+ flux assay . A more modern approach to analyse the NKCC and KCC activity consists in measurement of the 86Rb+ flux through
the membrane. This approach was used successfully to clone and characterize NKCC1 (Gamba et al., 1994; Xu et al., 1994), KCC1 (Gillen
et al., 1996) and KCC2 (Payne, 1997), and continues to be extensively utilized for characterization of different mutants and variants of CCC.
Although the above approaches strongly contributed to study the functional properties of CCC in homogenous cell preparations
(erythrocytes, oocytes, different heterologous cell lines), they have limited applications for studying tissues composed of different cell
types (i.e., brain slices, neuronal cultures). For example, using 86Rb+ it is difficult to discriminate in brain slices between the activity of
NKCC1 in neuronal cells and surrounding glial cells. Moreover, the radioactive approach does not allow resolution of ion concentration
changes at the subcellular level. Finally, the use of radioactive isotope raises the questions of potential toxicity and health hazard and
imposes important security restriction.
TL+ flux assay . This method is based on the use of Thallium (Tl+) as the K+ tracer. Recent reports have shown that Tl+ binds with high
affinity to the K+ ion site on the KCC2 (Zhang et al., 2010) and NKCC2 (Carmosino et al., 2013) and, once having crossed the plasma
membrane, could be efficiently detected using metal-sensitive fluorescent dyes (Delpire et al., 2009; Hartmann et al., 2010; Zhang et al.,
2010; Carmosino et al., 2013).
NH+4 flux assay . NH
+
4 uptake measures indirectly the activity of KCCs and NKCCs, which are highly-efficient carriers of NH
+
4 at their
K+ site (see Williams and Payne, 2004 for detailed review and analysis of KCC2 selectivity). Several groups have used this property
of CCC proteins to estimate KCC2 activity by measuring NH+4 -dependent changes of pHi (Williams and Payne, 2004; Titz et al., 2006;
Hershfinkel et al., 2009). This approach allows the analysis of KCC2 activity on the cellular and subcellular level as well as the esti-
mation of KCC2 activity in real time. The inconveniences of the approach are related to the complex changes of the pHi in response
to the application of the solution containing NH+4 (KCC2-independent alkalinisation followed by KCC2-dependent acidification) and pos-
sible contamination of pHi changes by functioning of other transporters, channels and ion exchangers. In addition, similarly to Tl+
method, the NH+4 approach measures KCC2 activity in reverse mode that increases [Cl
−]i and places recorded cells in non-physiological
conditions.
Thus, the methods described above allow measurement of the intrinsic transport carried by KCC transporters. These methods are
designed to measure cation influx, i.e., to analyse KCC2 activity in reverse mode that is not its physiological function and will cause an
increase of [Cl−]i. Accordingly, the potency of Tl+ and NH+4 methods to detect the ion flux mediated by endogenous KCC transporters
under physiological conditions remains to be demonstrated.
A recording of Cl− is a highly efficient alternative to the cation methods of CCC activity measurements under conditions close to
physiological. Numerous works have shown that KCC2 activity leads to strong changes in the intracellular Cl− concentration (reviewed by
Ben-Ari et al., 2007; Blaesse et al., 2009). The estimate ion of [Cl−]i in neuronal cells could be achieved via different methods. Here we
provide a brief description of different ways of estimating [Cl−]i and emphasize their relative advantages and limitations.
Gramicidin perforated patch clamp (GPPC) recording. The method is based on the use of the antibiotic gramicidin that makes
cation-selective pores in the membrane; the patch pipette is filled with gramicidin and thus, preserves [Cl−]i (Ebihara et al., 1995;
Kyrozis and Reichling, 1995). The concentration of Cl− is estimated using the Nernst equation after recording the reversal poten-
tial of GABAA or glycine receptor-channels that are Cl−-permeable. Using the GPPC approach, multiple studies have characterized
KCC2-dependent changes in [Cl−]i (Balakrishnan et al., 2003; Chudotvorova et al., 2005; Lee et al., 2005; Nardou et al., 2011; Ivakine
et al., 2013). The main advantage to GPPC recording is the estimation of [Cl−]i with high precision at single cell level. Unfortunately,
this method has numerous limitations that should be taken into consideration: (i) it affects [K+]i , given that KCC2 uses K+ as
main co-carrier, this should be taken into consideration when interpreting the result obtained with this method; (ii) most of the
measurements using GPPC are made in voltage clamp mode of patch clamp recording, and the imposed holding potential provides
an additional driving force for Cl− ions, affecting the kinetics of Cl− influx or efflux, and thus possibly confounding interpretations
of [Cl−]i; (iii) the GPPC method has limited application to record [Cl−]i in immature neurons, which harbors high input resistance
(Tyzio et al., 2003).
Single GABAA channel recording (SGCR). This method is a non-invasive way to estimate the driving force of GABAA using
cell-attached recording of single GABAA receptor currents. This approach was used successfully to characterize the developmental
(Continued)
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shift of GABA from depolarizing to hyperpolarizing (Tyzio et al., 2006, 2008). The main advantage of this method is that it is a non-invasive
way of estimating the exact difference between the levels of the resting membrane potential and the reversal potential of GABAAR-
mediated currents. Limiting points of the method are that there is a labor intensive aspect to data recording and analysis, and there is a
requirement of simultaneous single-channel-based recording of resting membrane potential (Tyzio et al., 2003, 2008).
Soma-to-dendrite Cl− gradient. To assess Cl− homeostasis and the dynamics of chloride removal in cortical neurons, Jarolimek et al.
(1999) and Kelsch et al. (2001) proposed an elegant approach based on whole cell recording of the differences between EGABA in soma
and dendrites. The EGABA in the soma is determined by the high [Cl−]i diffused from the patch pipette, whereas EGABA in dendrites is
more negative (i.e., [Cl−]i is lower due to active extrusion by KCC2) (Kelsch et al., 2001). This approach was successfully used by several
groups to monitor KCC2 activity in different types of neurons (Khirug et al., 2005; Li et al., 2007; Chamma et al., 2013) and neuronal
compartments (Khirug et al., 2008). The advantage of the approach is that it allows a determination of “pure” Cl−-extrusion capacity
under given experimental conditions. The inconvenience is that the values could be strongly influenced by efficiency of neuron perfusion
with intracellular solution (serial resistance, dendrites diameter). In addition, the cell perfusion with intracellular solution may affect KCC2
phosphorylation and, thus, modify its activity.
Fluorescent probes (DYES). The recent achievements in cell biology and microscopy have promoted the use of different Cl−-sensitive
fluorescent probes for analysis of neuronal Cl− homeostasis. The first set of markers were Cl−-sensitive dyes (quinolinium Cl− indicators)
exploiting the property of halides to quench the fluorescence of heterocyclic organic compounds with quaternary nitrogen (Chen et al.,
1988; Verkman, 1990). These compounds have relatively good sensitivity and selectivity to Cl−, and have been used in a variety of
preparations. A disadvantage is that a ratiometric recording cannot be performed and their use is strongly limited due to a strong bleaching
and the presence of a significant leakage rate (see review Bregestovski et al., 2009). The use of two-photon microscopy has largely
resolved bleaching-related problems, and has caused a rediscovery in the use of the quinolinium Cl− indicators (Kovalchuk and Garaschuk,
2012).
YFP-based markers. A more recent and promising method for non-invasive analysis of Cl− is based on the halide-binding properties
of yellow fluorescent protein (YFP) and its derivatives (Wachter and Remington, 1999; Jayaraman et al., 2000). Based on Cl−-sensitive
variants of YFP, ratiometric probes allowing estimation of the approximate level of [Cl−]i have been created. The first ratiometric Cl−
indicator was designed by fusion of YFP with cyan fluorescent protein (CFP) through a polypeptide linker (Kuner and Augustine, 2000).
In this construct, called Clomeleon, CFP served as a reference point for normalizing expression levels. The apparent EC50was 167mM.
Later a more sensitive probe was developed, termed “Cl-Sensor,” composed of CFP and a mutated form of YFP with higher Cl− sensi-
tivity (YFPCl, the apparent EC50 ∼ 30–50mM) (Markova et al., 2008; Waseem et al., 2010). Finally, recent work reported engineering of
one more Cl− sensitive ratiometric construct called SuperClomeleon that apparently has five-fold higher Cl− sensitivity than Clomeleon
(Grimley et al., 2013). Transgenic mice encoding Clomeleon (Berglund et al., 2006) and Cl-Sensor (Batti et al., 2013) have been successfully
created.
Both Clomeleon and Cl-Sensor have been effectively used to characterize changes in [Cl−]i driven by KCC2 and/or NKCC1 in neuronal
cells (Dzhala et al., 2005; Duebel et al., 2006; Pellegrino et al., 2011; Chamma et al., 2013). These YFP-based Cl−-sensitive biosensors
have a number of advantages: (i) they show much more stable fluorescence at long-lasting monitoring as compared to fluorescent dyes;
(ii) they allow excitation in the visible range of wavelength; (iii) they can be targeted to specific cell types either using plasmid transfection
(Waseem et al., 2010; Pellegrino et al., 2011; Chamma et al., 2013) or by transgenic creation of animals with knocked-in genes (Berglund
et al., 2006; Batti et al., 2013); (iv) they have a high molecular weight, which prevents the diffusion of the indicators from cells and (v) they
are suitable for ratiometric measurements. The limiting points of both Clomeleon and Cl-Sensor are: (i) the relatively high rate of bleaching
of the fluorescent signal (Kuner and Augustine, 2000; Berglund et al., 2011), (ii) the sensitivity of the probe to intracellular pH (pHi) and
some organic anions (Jayaraman et al., 2000).
To avoid bleaching of Clomeleon, several groups have successfully used two-photon microscopy (reviewed by Berglund et al.,
2011). We reported an alternative method that allows a stable ratiometric recording of Cl-Sensor fluorescence using a conventional
epifluorescent microscope (Friedel et al., 2013). The method is based on the discovery of transient inactivation of Cl-Sensor by short
wavelength (440 nm) blue light and the corresponding modification of excitation light pass and fluorescence recording procedure. The
bypassing of the problem of pH sensitivity of YFP-derived Cl− markers is more problematic as many cellular processes, including
activation of GABAA receptors, often involve concomitant changes in both Cl− and H+ ion concentration (Russell and Boron, 1976; Kaila
et al., 1989). Therefore, a researcher using YFP-based sensors as Cl- indicators should be aware that, even after precise calibration of the
set-up, the obtained values of [Cl−]i are only indicative.
E2GFP-based Cl− markers. To circumvent the problem of the pHi sensitivity, Arosio et al. (2010) developed a new ratiometric biosen-
sor (ClopHensor) composed of the Cl− and pH sensitive GFP mutant, E2GFP, fused to monomeric DsRed fluorescent protein and
allowing simultaneous measurement of Cl− and pH. Some new modifications of this sensor allowing its membrane targeting and
improving pH sensitivity have also been described (Mukhtarov et al., 2013). Another recent work (Raimondo et al., 2013) developed
one more ClopHensor derivative designated for expression into neuronal cells (ClopHensorN). Authors found that, when expressed in
neurons, DsRed component of ClopHensor formed dense intracellular aggregations that compromised correct ratiometric measurement.
The problem has been resolved by replacing DsRed with a tandem dimer tomato (TdTomato). Raimondo et al. (2013) performed also
(Continued)
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detailed analysis of the dynamic of neuronal [Cl−]i and pHi following activation of synaptic and extrasynaptic GABAA receptors that could
serve as manual for future works.
In summary, there is a large number of methodological approaches successfully used to assay indirectly the KCC2 activity. So far,
each approach has some advantages, but has also limitations that must be taken into account when interpreting results. This is why
many groups use a combination of at least two different approaches to corroborate results (i.e., Williams and Payne, 2004; Li et al., 2007;
Hershfinkel et al., 2009; Pellegrino et al., 2011; Chamma et al., 2013).
KCC2 mutants whose properties require more detailed analysis.
Therefore, after careful and detailed critical analysis of both stud-
ies we propose that KCC2 might be membrane raft-associated
protein, but additional experimental works are required from
independent groups to clarify the role of lipid rafts in KCC2
functioning.
In summary, KCC2 is an important transporter controlling
neuronal ion homeostasis and involved in several neurological
disorders. The activity of this transporter could be rapidly mod-
ulated via large number of signaling pathways. The majority of
these pathways remain to be characterized. In theBox 1, we review
the existing methods used to study KCC2 activity in an attempt to
help investigators in designing experiments to answer the many
fundamental questions regarding KCC2 functional regulation.
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